Methyltransferase inhibitors: changing the treatment algorithm for myelodysplastic syndromes.
List
Alan
A
Hematologic Malignancies Program, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA. listaf@moffitt.usf.edu
D000367:Age Factors; D001374:Azacitidine / Q000627:therapeutic use; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006801:Humans; D008780:Methyltransferases / Q000037:antagonists & inhibitors*; D009190:Myelodysplastic Syndromes / Q000175:diagnosis / Q000188:drug therapy*; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D018570:Risk Assessment / Q000379:methods; D033581:Stem Cell Transplantation
D004791:Enzyme Inhibitors; D008780:Methyltransferases; D001374:Azacitidine